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Abstract
Bovine anaplasmosis is a disease of worldwide economic importance caused by the rickettsia Anaplasma marginale.
Several major surface proteins with conserved gene sequences have been examined as potential candidates for vaccines.
One of these proteins, MSP1a, is expressed from the single copy msp1 gene. The molecular weight of MSP1a varies
among the geographic isolates of A. marginale because of a varying number of tandem repeated peptides of 28-29 amino
acids. In the present study, the sequence of the msp1 gene of Anaplasma marginale Havana isolate was determined, with
a size of 2,043 kb, demonstrating the presence of five tandem repeated regions. This gene was cloned into the eukaryotic
expression vector pCIneo, transfected in COS-7 cells and expression verified by immunofluorescence. These data provide
a basis for an immunization strategy using the msp1 gene in DNA immunization containing single or multiple genes
encoding major surface proteins of A. marginale.
Additional key words: bovine anaplasmosis, major surface protein, MSP1a, rickettsia.
Resumen
Nota corta. Secuenciación del gen msp1 del aislado Habana de Anaplasma marginale y expresión en células
eucariotas
La anaplasmosis bovina es una enfermedad causada por la rickettsia Anaplasma marginale que afecta al ganado
bovino. Las principales proteínas de la superficie codificadas por genes con secuencias conservadas constituyen
candidatos potenciales para vacunas. Dentro de estas proteínas, MSP1a es expresada por un gen de copia simple (msp1).
El peso molecular de MSP1a varía entre aislados de A. marginale de diferentes regiones geográficas, debido a la
presencia, en número variable, de una secuencia de 28-29 aminoácidos repetida en tándem. En el presente estudio se
secuenció el gen msp1 del aislado Habana de A. marginale, de 2.043 kb, demostrando la presencia de cinco regiones
repetidas en tándem. Se clonó este gen en un vector de expresión eucariota (pCIneo), se transfectó en células COS-7 y se
verificó la expresión de la proteína MSP1a por inmunofluorescencia, demostrándose la expresión de este gen procariota
en células eucariotas. Estos datos proporcionan las bases para la utilización de este gen en futuras estrategias de
inmunizaciones de DNA conteniendo uno o varios genes que codifican para proteínas principales de superficie de A.
marginale.
Palabras clave adicionales: anaplasmosis bovina, MSP1a, principales proteínas de superficie, rickettsia.
Anaplasma marginale, a member of the genogroup II
of the Ehrlichias in the order Rickettsiales (Walker and
Dumler, 1996), infects and replicates within the bovine
erythrocyte. Like other pathogenic ehrlichias, A.
marginale is biologically transmitted by ticks and in a
mechanical way by mosquitoes and contaminated
material. The disease is characterized by a noticeable
anaemia, weight loss and, in 34% of clinical cases, death
of the animal (Alderink and Dietrich, 1981). The
external membrane fraction of A. marginale comprises
at least six main polypeptides on the surface, which
include the main proteins (MSPs), MSP1a, MSP1b,
MSP2, MSP3, MSP4 and MSP5 (Tebele et al., 1991;
Visser et al., 1992). Immunization with native proteins
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MSP1 or MSP2 induces protection in experimental
infections, shown by a significant reduction in
rickettsemia and the anaemia, when compared with the
control (Palmer et al., 1989). Specific antibodies against
MSP1 block the union of A. marginale to the erythrocyte
and opzonize the organism for phagocytosis by the
macrophages (Cantor et al., 1993). Nevertheless, in spite
of the results obtained using the native complex MSP1a
and b, immunization with recombinant MSP1a, MSP1b
or a combination of these two proteins has not induced
significant protection (Palmer and McElwain, 1995).
MSP1a is encoded by a simple copy gene and is
invariable within a strain. Although the gene is not part
of a multigenic family there are differences between
strains, by changes in the number of sequences repeated
in tandem and other nucleotide substitutions, which
result in differences in the primary structure from the
polypeptide MSP1a (Allred et al., 1990). In spite of the
polymorphism of MSP1a between isolates, the epitope
sensitive to neutralization is conserved (Palmer et al.,
1988), and, therefore, its importance in the design of a
vaccine against the bovine anaplasmosis.
According to the results obtained by McGarey et al.
(1994), MSP1a and MSP1b have functions of surface
adhesins in charge of the adhesion of A. marginale to the
bovine erythrocyte, as a part of the invasion process.
This indicates the potential of A. marginale membrane
proteins to be used as components of recombinant or
nucleic acid vaccines for anaplasmosis. For these
reasons, the use of MSP1a in a DNA-based vaccine
against bovine anaplasmosis was investigated
(Arulkanthan et al., 1999).
DNA vaccines consist of a vector for expression in
eukaryotic cells that contains the gene or genes of
interest (Donelly et al., 1997). A eukaryotic promoter
directs the expression and the transcription is finished
by a signal of polyadenylation in the eukaryotic cell.
The intramuscular or intradermic inoculation of the
DNA vaccine into the animal cell causes the protein to
be expressed in vivo (Davis et al., 1993). The antigens
expressed in an endogenous form are processed and
presented in the context of molecules of the
histocompatibility complex (MHC) class I and class II,
inducing specific cellular responses (lymphocytes
CD4+ and CD8+) and antibody responses in the
immunized host (Lekutis et al., 1997). The objective of
the present study was to obtain the sequence of the
msp1 gene of A. marginale, Havana isolate, as well as
to subclone this gene in a vector for expression in
eukaryotic cells, to be used as an antigen model to
evaluate the potential of DNA immunizations against
bovine anaplasmosis.
The msp1 gene was amplified by PCR using the
following primers: 5GGAAGATCTTCCATGTCAGC
AGAGTATG3 and 5GGAAGATCTTCCTTACGCCGCC
GCCTG3, corresponding to flanking regions of this
gene, for Florida isolate (accession numbers M32871,
M32872). These primers were used in a PCR assay to
amplify DNA of Anaplasma marginale Havana isolate.
Briefly, target DNA (50 ng) was amplified in a mixture
of 0.4 mM deoxynucleoside triphosphates, 0.5 M each
primer, 20 mM MgCl2, 100 mM KCl, 200 mM
Tris-HCl (pH 8.2), 60 mM (NH4)2SO4, 1% Triton
X–100, 100 g ml–1 of nuclease-free bovine serum
albumin, and 2.5 U of native Pfu DNA polymerase
(Promega). PCR was performed at 94C for 2 min,
followed by 30 cycles of 94C for 1 min, 55C for 1
min, 72C for 2 min, with a final extension step at 72C
for 10 min. The amplicon was analyzed by gel
electrophoresis on a 0.8% agarose gel in 1X TBE buffer
(89 mM Tris, 89 mM boric acid, 2 mM disodium
EDTA), containing ethidium bromide 0.5 g ml–1. PCR
product was purified by using the QIAquick Spin PCR
purification kit (Qiagen, Inc., Chatsworth, Calif) as
described by the manufacturer. The DNA was eluted in
30 l of 10 mM Tris-HCl, pH 8.3.
The amplicon was cloned in a vector for expression in
E. coli, pMAL (New England Biolabs) (data no
presented) and the sequence was determined by the
French Company Express Genome, using the same
primers. Analysis and alignment of the sequence were
done using the DNAsis program. In order to confirm the
sequence identity, this was analyzed in the Blastn and
Blastx, respectively (http: www.ncbi.nlm.nih.gov/).
The sequence obtained for the msp1 gene of
Anaplasma marginale Havana isolate and for the
MSP1a protein were deposited in the GeneBank with
accession number AY489564, reporting a 2043 bp and
681 amino acids (aa), respectively.
The number of repeats (each 87 or 84 bp long) can
be determined from the size of the resulting amplicon,
because the 268 bp preceding and the 17 bp following
the repeats are conserved in all strains (Palmer et al.,
2001, 2004). The presence of 5 regions repeated in
tandem, in the Havana isolate, located at the
beginning of the gene, with 84 to 87 bp (28 to 29 aa),
immediately after the first 30 bp of the coding region,
are observed showing a sequence similar to that of the
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Florida isolate (Table 1). The repeated sequences vary
minimally with remainders of 25 aa completely
conserved.
The pMAL plasmid, containing the msp1 gene of
A. marginale Havana isolate was used to subclone this
gene in a pCIneo plasmid (Promega). The inserted
msp1 gene and the plasmid were purified using the
QIAquick gel extraction kit protocol (QIAGEN,
28704). The ligation of fragments was made using a
DNA ligation kit (Amersham, RPN 1507). The product
was transformed into Xl-2 Blue cells (ultracompetent
and supercompetent cells, Stratagene), using the
protocol of transformation in 5 min described by Pope
and Kent (1996). Selection of recombinants was done
by PCR using primers T7 and T3 (Promega), in a final
reaction volume of 25 l containing PCR buffer 1X
(Promega), 0.4 mM deoxynucleoside triphosphates,
0.5 M each primer, 0.5 U of Taq polymerase
(Promega). PCR was performed at 94C for 2 min,
followed by 30 cycles at 94C for 1 min, 55C for 1
min, 72C for 2 min, with a final extension step at 72C
for 10 min. The results were visualized in a 0.8%
agarose gel in TBE 1X, with ethidium bromide 0.5 g
ml–1. The colonies positive by PCR were analyzed with
EcoR I (Promega) and Xba I (Promega) restriction
enzymes and the sense of direction of the cloned
fragment was analyzed by digestion with Nde I
(Promega). The resulting restriction enzyme digested
DNA was analyzed in a 0.8% agarose gel.
A clone containing a fragment of 2043 bp, in the
correct direction was produced and purified by
Endofree Plasmid Maxi (QIAGEN). The purity of the
DNA was confirmed by measuring the optical density
at 260 and 280 nm, followed by electrophoresis in an
agarose gel.
With the objective of verifying the expression of
MSP1a in the eukaryotic cells, COS-7 cells were
transfected with 5 g of DNA of recombinant plasmid
pCIneo/msp1 by plate of 65 cm2, maintained until a
confluence of 80% in the cell monolayer, using the
method of transfections with DEAE-Dextran
(Sambrook et al., 1989). The transfected plates were
left in DMEM medium (Sigma), supplemented with
5% bovine fetal serum (Sigma), for 72 h to 37C, 5%
CO2. The cells were harvested, and the cellular debris
was stored at –20C for immunofluorescence, to make
the immunodetection of the MSP1a protein.
After 72 h of transfection the coverslips with the
cells transfected with the recombinant plasmid and the
native plasmid were washed three times with PBS 1X
and fixed with cold acetone for 10 min. The
monoclonal antibody Ana22B1 was added (Vidotto et
al., 1994) and incubated in a humid chamber at 37C
for 1 h. This was followed by three washes with PBS
1X for 10 min and the addition of an antimouse
antiserum conjugated with fluoresceine isothiocianate
(Sigma), diluted 1/50 and incubated in the dark at 37C
for 1 h. After three washes with PBS 1X coverslips
were left to dry and observed under the fluorescent
microscope (Opton), following the methodology
described in the manual of the International Office of
Epizootics (OIE) (WHO, 1996).
The expression of pCIneo/msp1 in COS-7 cells
(Fig. 1), was observed by the presence of fluorescent
cells when these are transfected with the recombinant
plasmid (panel A). No signal was observed in the cells
transfected with the native plasmid (panel B),
demonstrating the functionality of this gene in
eukaryotic cells.
The msp1 gene is genetically stable during the
acute and persistent infection of A. marginale. It is a
single copy gene which does not change when cultured
in vitro, in ticks or animals (Brown et al., 1998; Barbet
et al., 1999).
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Table 1. Tandem repeat forms present in the Florida (FL), Virginia (VA), Washington (WA), Idaho (ID) (Allred et al., 1990)
and Havana (HA) variants of the MSP1a polypeptides
Forms Sequences
No. tandem repeats
FL VA WA ID HA
A DDSSSASGQQQESSVSSQS (EASTSS)QLG 1 1 0 0 1
B ADSSSAGGQQQESSVSSQSD (QASTSS)QLG 7 1 3 0 4
C ADSSSAGGQQQESSVSSQSG (QASTSS)QLG 0 0 1 0 0
D ADSSSASGQQQESSVSSQS (EASTSS)QLGG 0 0 0 5 0
E ADSSSASGQQQESSVSSQS (EASTSS)QLG 0 0 0 1 0
The MSP1a protein is an adhesin for the invasion
of A. marginale to the bovine erythrocyte and the
tick's cells. The molecular weight of this protein
varies between geographic isolates of A. marginale
by variation in the number of peptides repeated in
28-29 tandem amino acids. These repeated
sequences can be present from 1 to 8 times (Palmer
et al., 2001) and constitute markers for the
transmissibility by ticks, influencing the strategies
of control and the vaccine design by subunits (de la
Fuente et al., 2001a).
It has been described (Allred et al., 1990), that in the
sequence of this gene in the different isolates, five
forms of this sequence exist repeated in tandem. These
vary minimally with 25 aa completely conserved in the
five forms. This variation in the number of repeated
sequences can explain the size polymorphism existing
in this gene for the different isolates.
The different size of the coding sequence of this
gene and the different length of the polypeptide for
each studied isolate have been reported, with sizes of
2301 bp and 767 aa, 1779 bp and 593 aa, 1956 bp and
652 aa and 2124 bp and 708 aa in Florida, Virginia,
Washington and Idaho isolates respectively (Allred et
al., 1990), but in all cases the presence of the epitope
sensitive to neutralization is described. For the
Havana isolate the size was 2043 bp and 680 amino
acids, respectively. In this sense de la Fuente et al.
(2003a,b) characterized 11 isolates of Oklahoma and
found differences in the sequences of this gene for all
the isolates. Moreover, Palmer et al. (2001) found an
isolate that only had a single repeated region. In Table
1 it is possible to observe that the type of repeated
sequences of the Havana isolate agrees with that
described for the Florida isolate (Allred et al., 1990),
variation being evident only in the number of
repetitions, unlike the rest of the isolates, that besides
being different in relation to size, they also differed in
the type of repeated sequence. If the geographical
proximity of the two regions from where the isolates
(Havana and Florida) came is taken into account, it is
noteworthy that the Florida isolate, with relation to
the msp1 gene has a greater similarity with the
Havana isolate, compared with other isolates from
different regions of the United States, according to
Allred et al. (1990) and Palmer et al. (2001). In spite
of the difference in the sequences repeated in tandem
of this msp1 gene it has been found that a 6 aa
epitope required for neutralization is present on all
isolates and expresses immunity. This sequence was
present in the repeats of the Havana isolate, studied in
this work.
The study of these repeated sequences is very
important, because they include markers for the
transmissibility by ticks, but this gene cannot be
considered as a marker to characterize isolates from
different geographic regions (de la Fuente et al.,
2001a,b). It has been reported (de la Fuente et al.,
2001b) that MSP1a affects the infection and
transmission of A. marginale by ticks of the genus
Dermacetor. The mechanism of infection and
transmission of A. marginale by ticks is important to
formulate control strategies and to develop improved
vaccine against the anaplasmosis. In addition, this is of
extreme importance, because it is known that the
sequence of MSP1a is conserved during all the life
cycle of A. marginale, with no change in amino acids
(Bowie et al., 2002), indicating that this protein bound
to MSP1b is a potential vaccine candidate against the
anaplasmosis. Its important biological function within
the pathogenesis of bovine anaplasmosis makes it of
great interest as a future vaccine candidate. It may be
possible to develop DNA vaccines where the genes
can be cloned into plasmid combining several genes
encoding for major surface proteins of the initial bodies
of this hemoparasite. These proteins are targets for
the immune response against this microorganism and
DNA vaccines may induce a higher cellular and
humoral response. This could elicit higher protection
against the microorganism, judging from the results of
Arulkanthan et al. (1999), which indicated the
importance of this type of response in the immunity of
the anaplasmosis.
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Figure 1. Immunofluorescence results. A: COS-7 cells
transfected with pCIneo/msp1; B: COS-7 cells transfected
with pCIneo.
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